Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety.

作者: Halyna Kuznietsova , Natalia Dziubenko , Iryna Byelinska , Vasyl Hurmach , Andriy Bychko

DOI: 10.1080/1061186X.2019.1703189

关键词:

摘要: Pyrrole derivatives (PDs) chloro-1-(4-chlorobenzyl)-4-((3-(trifluoromethyl)phenyl)amino)-1H-pyrrole-2,5-dione (MI-1) and 5-amino-4-(1,3-benzothyazol-2-yn)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrole-3-one (D1) were synthesised as inhibitors of several protein kinases including EGFR VEGFR. The aim the study was to reveal exact mechanisms PDs' action VEGFR are involved in. We observed, that both PDs could bind with form stable complexes. entered into electrostatic interactions polar groups phospholipid heads in cell membrane, power interaction depended on nature PD radical substituents (greater for MI-1 smaller D1). Partial intercalation membrane hydrophobic zone also occurred. concentrations induced apoptosis malignant cells but normal ones had different sensitivity those. D1 acted like antioxidants inflamed colonic tissue, evidenced by reduce lipid peroxidation products (by 43-67%) increase superoxide dismutase activity 40 58%) restoring these values control ones. restored reduced haemoglobin normalised elevated platelets monocytes settings colorectal cancer, whereas only platelets. Thus, be used competitive antioxidants, which might contribute realisation their anti-inflammatory, proapoptotic antitumor activity.

参考文章(105)
Halyna M. Kuznietsova, Vasyl V. Hurmach, Andriy V. Bychko, Olena I. Tykhoniuk, Demyd S. Milokhov, Olga V. Khilya, Yulian M. Volovenko, Volodymyr K. Rybalchenko, Synthesis and biological activity of 4-amino-3-chloro-1H-pyrrole-2,5-diones. In Silico Pharmacology. ,vol. 7, pp. 1- 10 ,(2019) , 10.1007/S40203-019-0051-2
Fang Chen, Gangliang Huang, Application of glycosylation in targeted drug delivery European Journal of Medicinal Chemistry. ,vol. 182, pp. 111612- ,(2019) , 10.1016/J.EJMECH.2019.111612
Prakash Bethapudi, Syed Hussain Basha, Firoz. A, Sreenivasa reddy E, Majji Rambabu, Anti-angiogenesis property by Quercetin compound targeting VEGFR2 elucidated in a computational approach European Journal of Biotechnology and Bioscience. ,vol. 2, pp. 30- 46 ,(2014)
Wang Cai, Bing Song, Hao Ai, Combined inhibition of FGFR and mTOR pathways is effective in suppressing ovarian cancer. American Journal of Translational Research. ,vol. 11, pp. 1616- 1625 ,(2019)
Masabumi Shibuya, VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases. Endocrine‚ Metabolic & Immune Disorders-Drug Targets. ,vol. 15, pp. 135- 144 ,(2015) , 10.2174/1871530315666150316121956
David E. Gerber, Targeted therapies: a new generation of cancer treatments. American Family Physician. ,vol. 77, pp. 311- 319 ,(2008)
Ahmet Özer Şehirli, E. Tatlıdede, Meral Yüksel, Şule Çetinel, C. Erzi̇k, Berrak Yeğen, Göksel Şener, Protective effects of alpha-lipoic acid against oxidative injury in TNBS-induced colitis. erciyes medical journal. ,vol. 31, pp. 15- 26 ,(2009)
Daniel Cho, James W. Mier, Micheal B. Atkins, PI3K/Akt/mTOR Pathway: A Growth and Proliferation Pathway Humana Press. pp. 267- 285 ,(2009) , 10.1007/978-1-59745-332-5_15